2014-01-23 10:53:01 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Zhejiang Int l Group Co.,Ltd. (411) and produced a report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering Zhejiang Int l Group Co.,Ltd. (411). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Zhejiang Int l Group Co.,Ltd. investor.
Report Summary: Zhejiang Int l Group Co.,Ltd. is an average quality company with a neutral outlook. Zhejiang Int l Group Co.,Ltd. has medium business growth and is run by passable management. The trend in Zhejiang Int l Group Co.,Ltd. fair value exchange rate against its closest rated-competitor, China National Medicines Corporation Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, Zhejiang Int l Group Co.,Ltd. shows similar overvaluation and is equally
likely to underperform the market.
The report breaks down the Total StockMark into its three components - business, management and price, performing an in-depth analysis of Zhejiang Int l Group Co.,Ltd. for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext and from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, One source West Services, and Dow Jones/Factiva.
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering 31 different markets and over 22,000 companies. The StockMarks rating system is based on proven investment principles and is designed to drive long-term shareholder returns.